333 related articles for article (PubMed ID: 36928226)
1. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
Moheb N; Chen JJ
Eye (Lond); 2023 Aug; 37(12):2391-2398. PubMed ID: 36928226
[TBL] [Abstract][Full Text] [Related]
2. [Typical and atypical optic neuritis].
Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.
Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E
Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296
[TBL] [Abstract][Full Text] [Related]
4. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT].
Almer Z
Harefuah; 2022 Oct; 161(10):645-651. PubMed ID: 36315205
[TBL] [Abstract][Full Text] [Related]
5. An update on optic neuritis.
Kraker JA; Chen JJ
J Neurol; 2023 Oct; 270(10):5113-5126. PubMed ID: 37542657
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.
Sharma J; Bhatti MT; Danesh-Meyer HV
Clin Exp Ophthalmol; 2021 Mar; 49(2):186-202. PubMed ID: 33426799
[TBL] [Abstract][Full Text] [Related]
7. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
Bianchi A; Cortese R; Prados F; Tur C; Kanber B; Yiannakas MC; Samson R; De Angelis F; Magnollay L; Jacob A; Brownlee W; Trip A; Nicholas R; Hacohen Y; Barkhof F; Ciccarelli O; Toosy AT
Mult Scler; 2024 May; 30(6):674-686. PubMed ID: 38646958
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
Gospe SM; Chen JJ; Bhatti MT
Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
[TBL] [Abstract][Full Text] [Related]
9. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
Kaushik M; Burdon MA
J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
[TBL] [Abstract][Full Text] [Related]
10. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
Wildemann B; Horstmann S; Korporal-Kuhnke M; Viehöver A; Jarius S
Klin Monbl Augenheilkd; 2020 Nov; 237(11):1290-1305. PubMed ID: 33202462
[TBL] [Abstract][Full Text] [Related]
11. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius S; Aktas O; Ayzenberg I; Bellmann-Strobl J; Berthele A; Giglhuber K; Häußler V; Havla J; Hellwig K; Hümmert MW; Kleiter I; Klotz L; Krumbholz M; Kümpfel T; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Tumani H; Wildemann B; Trebst C;
J Neurol; 2023 Jul; 270(7):3341-3368. PubMed ID: 37022481
[TBL] [Abstract][Full Text] [Related]
12. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
[TBL] [Abstract][Full Text] [Related]
13. Neuro-ophthalmological Presentation of Optic Neuritis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Lin TY; Asseyer S; Buenrostro GS; Feldmann K; Hamann S; Paul F; Zimmermann HG
Klin Monbl Augenheilkd; 2022 Nov; 239(11):1305-1314. PubMed ID: 35995144
[TBL] [Abstract][Full Text] [Related]
14. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
15. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
Stiebel-Kalish H; Rubarth K; Shouchane-Blum K; Tiosano A; Lotan I; Hellmann MA; Wilf-Yarkoni A; Bialer O; Flanagan EP; Pittock SJ; Bhatti MT; Schmitz-Hübsch T; Paul F; Asseyer S; Chen JJ
Sci Rep; 2022 Dec; 12(1):21312. PubMed ID: 36494385
[TBL] [Abstract][Full Text] [Related]
16. Update on glial antibody-mediated optic neuritis.
Song H; Zhou H; Wei S
Jpn J Ophthalmol; 2022 Sep; 66(5):405-412. PubMed ID: 35895155
[TBL] [Abstract][Full Text] [Related]
17. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Kaneko K; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
J Neurol Sci; 2022 Jun; 437():120269. PubMed ID: 35483239
[TBL] [Abstract][Full Text] [Related]
19. Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore.
Foo R; Yau C; Singhal S; Tow S; Loo JL; Tan K; Milea D
Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):184-195. PubMed ID: 35533337
[TBL] [Abstract][Full Text] [Related]
20. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
